Article
Current therapies for chronic hepatitis C.
Pharmacotherapy - 1 Jan 2011
Ferguson McKenzie C
Abstract excerpt
Hepatitis C virus affects more than 180 million people worldwide and as many as 4 million people in the United States. Given that most patients are asymptomatic until late in the disease progression, diagnostic screening and evaluation should be performed in patients who display high-risk behaviors associated with acquisition of hepatitis C. Chronic hepatitis C is associated with cirrhosis, hepatic failure, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
